comparison of Ropivacaine and bupivacaine for injection into the lower back for doing endoscopic urological surgeries
- Conditions
- Patients posted for elective urological surgeries
- Registration Number
- CTRI/2018/05/014252
- Lead Sponsor
- Sri BM patil Medical college
- Brief Summary
The aim of our study is to compare the clinical effect of 0.75% intrathecal isobaric ropivacaine with 0.5% intrathecal hyperbaric bupivacaine. Group 1 patients received 3 ml of hyperbaric bupivacaine and Group 2 patients received 2 ml of 0.75% isobaric ropivacaine. Both the groups were compared for onset of sensory block, onset and duration of motor block, highest level of sensory block. There was no significant diffrence between the two groups in mean time to onset of sensory block at T10, 5.79+/- 1.38 minute with ropivacaine and 5.68+/-1.57 minute with bupivacaine. Highest level of sensory block attained was T6 in both groups. From the study we concluded that 2ml 0.75% ropivacaine provided comparable quality of sensory block but had slower onset and significantly shorter duration compared to 3ml 0.5% bupivacaine
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 142
ASA 1, 2& 3 scheduled for urological surgery under spinal anaesthesia.
1.Patients with contraindication to spinal anaesthesia 2.patient with history of allergy to amide local anaesthetics.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Onset of sensory block, onset and duration of motor block, highest level of sensory block After intrathecal injection of drug to end of procedure
- Secondary Outcome Measures
Name Time Method Quality of anaesthesia and muscle relaxation, haemodynamic parameters and adverse effects if any were studied After intrathecal injection of drug to end of procedure
Trial Locations
- Locations (1)
Sri BM patil Medical college
🇮🇳Udupi, KARNATAKA, India
Sri BM patil Medical college🇮🇳Udupi, KARNATAKA, IndiaAbhishek Rao KordcalPrincipal investigator09886118906kordcal85@gmail.com